Qian Wang

Qian Wang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
NLNing Liang
Ning Liang
TYTao Yang
Tao Yang
QHQian Huang
Qian Huang
PYPengfei Yu
Pengfei Yu
CLChaoxu Liu
Chaoxu Liu
XHXianli He
Xianli He
Primary liver cancer mainly includes the following four types: hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), hepatoblastoma (HB), and combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CCA). Recent studies have indicated that there are differences in cancer stem cell (CSC) properties among different types of liver cancer. Liver cancer stem cells (LCSCs), also called liver tumor-initiating cells, have been viewed as drivers of tumor initiation and metastasis. Many mechanisms and factors, such as mitophagy, mitochondrial dynamics, epigenetic modifications, the tumor microenvironment, and tumor plasticity, are involved in the regulation of cancer stemness in liver cancer. In this review, we analyze cancer stemness in different liver cancer types. Moreover, we further evaluate the mechanism of cancer stemness maintenance of LCSCs and discuss promising treatments for eradicating LCSCs.

8 December 2022 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
GWGang Wang
Gang Wang
XHXianli He
Xianli He
QWQian Wang
Qian Wang

12 June 2023 in Metabolism
Verified
Journal Article
Closed access
TYTao Yang
Tao Yang
NLNing Liang
Ning Liang
JZJiahao Zhang
Jiahao Zhang
YBYaxing Bai
Yaxing Bai
YLYuedan Li
Yuedan Li
HZhongxin zhang
hongxin zhang

11 September 2022 in Cancer Letters
Verified
Journal Article
Closed access
QWQian Wang
Qian Wang
PYPengfei Yu
Pengfei Yu
CLChaoxu Liu
Chaoxu Liu
XHXianli He
Xianli He
GWGang Wang
Gang Wang

23 September 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
ZQZhaoyan Qiu
Zhaoyan Qiu
NLNing Liang
Ning Liang
QHQian Huang
Qian Huang
TSTao Sun
Tao Sun
HXHongyuan Xue
Hongyuan Xue
QWQian Wang
Qian Wang
Background: Dual-specificity phosphatase 9 (DUSP9) belongs to the dual-specificity protein phosphatase subfamily. Recently, increasing attention has been paid on the role of DUSP9 in a variety of cancers. However, its functional role in tumor development is still unclear, especially in colorectal cancer (CRC). Methods: The functional role of DUSP9 in inhibiting the progression of CRC was verified using colony formation assay, wound healing assay, nude mice xenograft model, etc. RNA-seq was performed to assess the gene expression profiling in SW480 cells with DUSP9 stable knockdown and shControl cells. Bisulfite sequencing (BSE) was performed to reveal the methylation status of CpG island in the promoter of DUSP9. Results: DUSP9 was significantly downregulated in tumor tissues compared with peritumor tissues. Mechanistically, the high methylation status of CpG island in the promoter of DUSP9 may lead to the downregulation of DUSP9 in CRC. Clinically, low DUSP9 expression in CRC was closely associated with depth of invasion, metastasis (TNM) stage, and poor survival, indicating that DUSP9 may be involved in the progression of CRC. Functional study revealed that DUSP9 inhibited proliferation, migration, invasion, and epithelial–mesenchymal transition of CRC cells both in vitro and in vivo. Transcriptome profiling studies revealed that Erk signaling was involved in the tumor progression mediated by DUSP9 silencing, which is confirmed by cell experiments and clinical tissue sample staining analysis. Conclusion: Our findings demonstrate that DUSP9 plays a critical role in the progression of CRC, and therapeutic intervention to increase the expression or activity of DUSP9 may be a potential target for CRC treatment in the future.

15 September 2023 in British Journal of Cancer
Verified
Journal Article
Closed access
PDF file
QWQian Wang
Qian Wang
NLNing Liang
Ning Liang
CLChaoxu Liu
Chaoxu Liu
JLJing Li
Jing Li
YBYaxing Bai
Yaxing Bai
GWGang Wang
Gang Wang